4 Papers
18 Citations
Anthony Rowe is an academic researcher from Commonwealth Scientific and Industrial Research Organisation. The author has contributed to research in topics: Multinucleate & Nanoparticle. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Long-term exposure to commercially available sunscreens containing nanoparticles of TiO2 and ZnO revealed no biological impact in a hairless mouse model.
Megan J. Osmond-McLeod,Yalchin Oytam,Anthony Rowe,Fariborz Sobhanmanesh,G.E. Greenoak,Jason K. Kirby,Elizabeth F. McInnes,Maxine J. McCall +7 more
TL;DR: This long-term study provided no basis to avoid the use of sunscreens containing metal oxide nanoparticles, and mice exposed to UVR developed statistically significant incidences of histologically-diagnosed malignant and benign skin neoplasms.
Should Scientific Research Involving Decapod Crustaceans Require Ethical Review
TL;DR: To balance animal welfare concerns with scientific merit whilst providing confidence for the growing public awareness of crustacean welfare, use of decapod crustaceans in research should require ethical review.
14
Coencapsulation of Target Effector Cells With Mesenchymal Stem Cells Reduces Pericapsular Fibrosis and Improves Graft Survival in a Xenotransplanted Animal Model.
Vijayaganapathy Vaithilingam,Margaret D. M. Evans,Anthony Rowe,Penelope A Bean,Bernard E. Tuch +4 more
TL;DR: It is shown that coencapsulation of MSCs with target cells has a dose-dependent effect on reducing PFO and improving graft survival when implanted either intraperitoneally or subcutaneously in a stringent xenotransplantation setting.
10
Effect of Atmospheric-Pressure Plasmas on Drug Resistant Melanoma: The Challenges of Translating In vitro Outcomes into Animal Models
Musarat Ishaq,Anthony Rowe,Kateryna Bazaka,Mark B. Krockenberger,Margaret D. M. Evans,Kostya Ostrikov +5 more
- 01 Jan 2016
TL;DR: The results of this study corroborate an ROS-mediated mechanism of cancer cell death, with apoptosis in AP-treated Mel-007 melanoma cells inhibited by pretreatment of cells with the ROS scavenger N-acetylcysteine or the caspase inhibitor zVAD-fmk.